desipramine has been researched along with Chromosome Deletion in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Chromosome Deletion: Actual loss of portion of a chromosome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perona, MT | 1 |
| Waters, S | 1 |
| Hall, FS | 1 |
| Sora, I | 1 |
| Lesch, KP | 1 |
| Murphy, DL | 1 |
| Caron, M | 1 |
| Uhl, GR | 1 |
1 other study available for desipramine and Chromosome Deletion
| Article | Year |
|---|---|
Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.
Topics: Animals; Antidepressive Agents; Chromosome Deletion; Depressive Disorder; Desipramine; Disease Model | 2008 |